Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from Eiken Chemical Co., Ltd. ( (JP:4549) ).
Eiken Chemical Co., Ltd. has announced a leadership change, with Director and Representative Executive Officer Chairman Tsugunori Notomi set to retire at the end of his term. The decision was approved by the board and will be formally confirmed at a post–shareholders’ meeting board session following the 88th annual general shareholders’ meeting on June 23, 2026.
The retirement of Notomi as representative executive officer chairman is scheduled to take effect on June 23, 2026, marking a planned governance transition at the company. This move reflects routine leadership succession and may signal further adjustments in the executive structure as Eiken Chemical maintains continuity in its management and strategic direction.
More about Eiken Chemical Co., Ltd.
Eiken Chemical Co., Ltd. is a Japan-based medical and diagnostics company listed on the TSE Prime, known for developing and supplying clinical testing reagents and related products for healthcare institutions. The company focuses on diagnostic solutions that support disease detection and public health, serving hospitals, laboratories, and other medical providers in domestic and international markets.
Average Trading Volume: 176,271
Technical Sentiment Signal: Buy
Current Market Cap: Yen100.6B
Find detailed analytics on 4549 stock on TipRanks’ Stock Analysis page.